Nanobiotix (NBTX) Enterprise Value (2018 - 2025)

Nanobiotix's Enterprise Value history runs 8 years deep, the most recent figure standing at -$61.4 million for Q4 2025.

• On a quarterly basis, Enterprise Value fell 15.53% year-over-year to -$61.4 million in Q4 2025; TTM through Dec 2025 was -$61.4 million, a 15.53% decrease from a year earlier, with the FY2025 full-year figure at -$59.6 million, down 12.13% from the prior year.
• Enterprise Value declined to -$61.4 million in Q4 2025 per NBTX's latest filing, from -$32.6 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$23.6 million in Q2 2023 and bottomed at -$123.2 million in Q2 2021.
• The 5-year median for Enterprise Value is -$64.3 million (2022), against an average of -$65.2 million.
• Across the five-year window, Enterprise Value surged 64.98% in 2023 and plunged 203.3% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$96.0 million in 2021, then surged by 56.02% to -$42.2 million in 2022, then slumped by 91.82% to -$81.0 million in 2023, then soared by 34.38% to -$53.1 million in 2024, then dropped by 15.53% to -$61.4 million in 2025.
• Per Business Quant, the three latest NBTX Enterprise Value figures stand at -$61.4 million (Q4 2025), -$32.6 million (Q2 2025), and -$53.1 million (Q4 2024).